RESEARCH & DEVELOPMENT
Taking the first step in 1998, Cisen Pharmaceutical Co. Group has found the market for domestic therapeutic drug based on its philosophy of respecting life and affordable, quality and safe medicine.
We are strengthening our global market competitiveness by developing leading complex generic health care products. We are continuing our research and making efforts for the development of innovative, complex, quality drug products based on its long history and know-how accumulated in the field of therapeutic drugs.
Cisen Group, which has the global R & D facility, a differentiated technology and innovative complex generic drug products, is taking a lead forward to become a world-renowned pharmaceutical company.
Cisen Group has been able to make progress through the generous trust and support of our shareholders and customers. We will contribute to our shareholders, customers and the society so that we can return our faith and always do our best to be a proud Cisen group in the world.
RESEARCH INTEREST
Based on the long history and know-how in treatment and medicine field, parent company, the Cisen Pharmaceutical Co. Ltd, is constantly researching and developing innovative complex, safe and quality medicine.
We are targeting the diseases with high demand for medically unmet needs, concentrating on the development of innovative complex, affordable, safe and quality medicines using the Cisen Pharmaceutical’s unique technology and conducting research activities in line with global trends through open innovation.
RESEARCH CENTER
Research Center of Cisen Pharmaceuticals India Pvt. Ltd. for Pharmaceutical Research and Development of complex generic products for global markets is one step ahead of others in developing of new technology based products. The company builds core technology that is internationally competitive.
Cisen Pharmaceuticals India Pvt. Ltd. is establishing a comprehensive pharmaceutical research center in 2018, based on accumulated technology and outstanding capability.
In the 21st century, we created a strategy to focus on exploring with the goal of creating personalized treatments that fits into the patient’s requirement.
RESEARCH PIPELINE
We aspire to be a dynamic R&D organization by focusing on the best science and technology for those therapies that can deliver true quality and safe medicine to global patients. We will build disease area expertise in our core therapeutic areas with complex parental and solid oral generic pharmaceutical products, strengthen our pipeline and create an inspiring culture.
We propose to develop primarily following dosage forms:
Parenteral: Simple and Complex Injectables solution and suspension, SVP, LVP
Tablets: Immediate-release, Sustained-release, Delayed-release, Film-coated
Capsules: Powder, Granule filling
Pellets: Into tablets or Capsule filled
